Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-061394
Filing Date
2026-02-20
Accepted
2026-02-20 16:16:27
Documents
1
Period of Report
2026-02-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3924
  Complete submission text file 0001193125-26-061394.txt   5344
Mailing Address 39 OLD RIDGEBURY RD. SUITE 11 DANBURY CT 06810
Business Address
SCIASCIA THOMAS (Reporting) CIK: 0001229946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 26660148

Mailing Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)